CN102973845B - 一种治疗脚气的复方酊剂 - Google Patents
一种治疗脚气的复方酊剂 Download PDFInfo
- Publication number
- CN102973845B CN102973845B CN201210583270.0A CN201210583270A CN102973845B CN 102973845 B CN102973845 B CN 102973845B CN 201210583270 A CN201210583270 A CN 201210583270A CN 102973845 B CN102973845 B CN 102973845B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- cortex
- herba
- beriberi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- 229940098465 tincture Drugs 0.000 title abstract description 8
- 208000002474 Tinea Diseases 0.000 title abstract description 4
- 206010012504 Dermatophytosis Diseases 0.000 title abstract 2
- 241001460074 Microsporum distortum Species 0.000 title abstract 2
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- 241000903946 Clematidis Species 0.000 claims abstract description 13
- 241000221012 Viscum Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 206010047601 Vitamin B1 deficiency Diseases 0.000 claims description 40
- 208000002894 beriberi Diseases 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 16
- 229920003266 Leaf® Polymers 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 235000014066 European mistletoe Nutrition 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 12
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 241000405217 Viola <butterfly> Species 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000776124 Adiantum caudatum Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000064622 Physalis edulis Species 0.000 abstract 1
- 235000001982 Physalis edulis Nutrition 0.000 abstract 1
- 241001334794 Potentilla parvifolia Species 0.000 abstract 1
- 244000061458 Solanum melongena Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 235000015099 wheat brans Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 210000002683 foot Anatomy 0.000 description 13
- 201000004647 tinea pedis Diseases 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 208000003251 Pruritus Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 7
- 210000003371 toe Anatomy 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000009889 Herpes Simplex Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241000294743 Gamochaeta Species 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 208000010195 Onychomycosis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 208000023819 chronic asthma Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000005882 tinea unguium Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001094455 Cipangopaludina chinensis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 208000035286 Spontaneous Remission Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 229940084434 fungoid Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明的目的是提供一种治疗效果好、没有副作用、从排毒、消炎杀菌、修复、再活化皮肤细胞,促进表皮微循环使皮肤细腻,达到标本兼治效果的治疗脚气的复方酊剂。本发明的一种治疗脚气的复方酊剂是由以下重量配比的原料组成:每100份的乙醇中含:赤小豆10-20份、血藤10-20份、茄根10-20份、薏苡仁10-20份、五加皮8-15份、附子8-15份、小麦麸8-15份、地骨皮8-15份、威灵仙6-10份、黄柏6-10份、小叶金老梅6-10份、玉米须6-10份、紫花地丁4-8份、棱枝槲寄生4-8份、灯笼草4-8份、鞭叶铁线蕨4-8份、冰片1-10份、薄荷油1-10份。
Description
技术领域
本发明涉及一种治疗痤疮的药物,具体的说是一种治疗脚气的复方酊剂。
背景技术
脚气,祖国医学称为“臭田螺”、“脚气”、“脚气疮”、“脚气湿疮”、“湿脚气”、“足趾缝烂疮”、“烂疮”、“风痒脚疮”、“烂脚风”、“脚痔”。如《医宗金鉴·外科心法》:“此证由胃经湿热下注而生,脚丫破烂,其患虽小,其痒搓之不能解,必搓至皮烂,津腥臭水觉痛时,其痒方止,次日仍痒,经年不愈,极其缠绵。”该病虽发生在手、足局部,但常有瘙痒疼痛,有时因搔抓而继发化脓性感染,或引起淋巴结、淋巴管炎及丹毒、败血症等,对工作、身体健康均有一定影响,必须加以重视。脚气是足癣的俗名。有的人把“脚气”和“脚气病”混为一谈,这是不对的。医学上的“脚气病”是因维生素B缺乏引起的全身性疾病,而“脚气”则是由真菌(又称毒菌)感染所引起的一种常见皮肤病。洗脚盆及擦脚毛巾应分别使用以免传染他人。足癣如不及时治疗,有时可其它部位,如引起手癣和甲癣等,有时因为痒被抓破,继发细菌感染,会引起严重的并发症。中医称脚气为“脚弱”。《备急千金要方》卷二十二《风毒脚气方》:“然此病发,初得先从脚起,因即胫肿,时人号为脚气。深师云:脚弱者,即其义也”。
脚气是一种极常见的真菌感染性皮肤病。成人中70-80%的人有脚气,只是轻重不同而已。常在夏季加重,冬季减轻,也有人终年不愈。医学上通常将脚气分三型:糜烂型、水疱型、角化型脚气。
目前临床上治疗尚无特效药物。用于脚癣的临床治疗方法多是采用皮肤表面涂抹消炎、杀菌、止痒药膏,其治疗效果都不很理想,目前仍是医学界未能解决的难题。
发明内容
本发明的目的是提供一种治疗效果好、没有副作用、从排毒、消炎杀菌、修复、再活化皮肤细胞,促进表皮微循环使皮肤细腻,达到标本兼治效果的治疗脚气的复方酊剂。
本发明的治疗脚气的复方酊剂是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆10-20份、血藤10-20份、茄根10-20份、薏苡仁10-20份、五加皮8-15份、附子8-15份、小麦麸8-15份、地骨皮8-15份、威灵仙6-10份、黄柏6-10份、小叶金老梅6-10份、玉米须6-10份、紫花地丁4-8份、棱枝槲寄生4-8份、灯笼草4-8份、鞭叶铁线蕨4-8份、冰片1-10份、薄荷油1-10份。
制备方法:
1)、按配方比例将上述中药粉碎成300-400目的细粉备用;
2)、按配方比例将乙醇中加入粉碎后的细粉搅拌均匀,在于加入冰片勾兑,最后加入薄荷油搅拌均匀,于0-10℃温度下用超声波匀化10-30分钟,分装即为成品。
用法:外搽,每日3-4次,连用2-4周。适应症:各种类型的癣。
本发明的治疗脚气的复方酊剂是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆11-18份、血藤11-18份、茄根11-18份、薏苡仁11-18份、五加皮9-14份、附子9-14份、小麦麸9-14份、地骨皮9-14份、威灵仙7-9份、黄柏7-9份、小叶金老梅7-9份、玉米须7-9份、紫花地丁5-7份、棱枝槲寄生5-7份、灯笼草5-7份、鞭叶铁线蕨5-7份、冰片2-8份、薄荷油2-8份。
本发明的治疗脚气的复方酊剂是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆15份、血藤15份、茄根15份、薏苡仁15份、五加皮13份、附子13份、小麦麸13份、地骨皮13份、威灵仙8份、黄柏8份、小叶金老梅8份、玉米须8份、紫花地丁6份、棱枝槲寄生6份、灯笼草6份、鞭叶铁线蕨6份、冰片5份、薄荷油5份。
本发明涉及中药的药理及药性:
赤小豆:
【性味】性平,味甘、酸。入心、小肠经。
【功能主治】辟温疫,治产难,下胞衣,通乳汁,利水消种,解毒排脓。用于水肿胀满、脚气浮肿、黄疸尿赤、风湿热痹、痈肿疮毒、肠痈腹痛。
血藤:辛,温,无毒。功用主治:养血消瘀,理气化湿。治痨伤吐血,肢节酸疼,心胃气痛,脚气痿痹,月经不调,跌打损伤。
茄根:
【性味】性寒,味甘,有小毒。
【功能主治】治久痢便血,脚气,齿痛,冻疮;《纲目》:散血消肿,治血淋,下血,血痢,阴挺,齿匿,口蕈。
薏苡仁:
【性味】性凉,味甘、淡。
【功能主治】健脾渗湿,除痹止泻。薏米可用于治疗水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻。
五加皮:
【性味】味辛、温;归肝肾经。
【功能主治】祛风湿,壮筋骨,活血祛瘀。治风湿痹,筋骨挛急,腰痛,阳痿,
脚弱,小儿行迟,水肿,脚气,跌打劳伤。
附子:
【性味】辛、甘,大热;有毒;归心、肾、脾经。
【功能】回阳救逆,补火助阳,散寒止痛。“为回阳救逆第一品药”
【主治】用于阴盛格阳,大汗亡阳,吐泻厥逆,肢冷脉微,心腹冷痛,冷痢,脚气水肿,风寒湿痹,阳痿,宫冷,虚寒吐泻,阴寒水肿,阳虚外感,阴疽疮疡以及一切沉寒痼冷之疾。
小麦麸:
【性味】甘,寒,无毒;
【功能主治】治虚汗,盗汗,泄利,糖尿病,口腔炎,热疮,折伤,风湿痹痛,脚气。①《本草拾遗》:"和面作饼,止泄利,调中去热,健人。以醋拌蒸热,袋盛,熨腰脚伤折处,止痛散血。"②《日华子本草》:"治时疾热疮,汤火疮烂,扑损伤折,瘀血,醋炒贴窨。"③《纲目》:"醋蒸熨手足风湿痹痛,寒湿脚气,互易至汗出。末服止虚汗。"
地骨皮:
【性味】味甘、寒;
【功能主治】清热,凉血;虚劳潮热盗汗,肺热咳喘,吐血,衄血,血淋,消渴,高血压,痈肿,恶疮。
威灵仙:
【性味归经】味辛、咸,温。归膀胱经。
【功能主治】祛风湿,通经络,消痰涏,散癖积。治痛风、顽痹、腰膝冷痛,脚气,破伤风。
黄柏:
【性味归经】苦,寒。归肾、膀胱经。
【功能主治】清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿{辟},骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。
小叶金老梅:
【性味归经】甘;寒.肾;膀胱经.
【主治】寒湿脚气;痒疹;乳腺炎.
【功效】利湿;止痒;解毒。
玉米须:
【性味】性平,味甘淡,无毒。
【功用主治】利尿,泄热,平肝,利胆。治肾炎水肿,脚气,黄疸肝炎,高血压,胆囊炎,胆结石,糖尿病,吐血衄血,鼻渊,乳痈。
紫花地丁:
【性味归经】苦、辛、寒、无毒;归心、肝经。
【功用】可入药,其性寒味微苦,清热解毒,凉血消肿。主治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎;外敷治跌打损伤、痈肿、毒蛇咬伤等。
棱枝槲寄生:
【性味归经】辛、微涩、温。《西藏常用中草药》:"性平,味苦。"脾、肾经。
【功效主治】除湿、祛风。治肺病吐血,乳疮,腹痛。治风湿性关节炎,腰腿酸痛,高血压,胎动,乳少。
灯笼草:
【性味】《四川中药志》:"性寒,味苦,无毒。"
【功能主治】渗湿,杀虫。治黄疸,小便不利,慢性咳喘,疳疾,瘰疬,天泡疮,湿疮。清热利湿;被动痰止咳;软坚散结。主湿热黄疸;小便不利;慢性咳喘;疳疾;瘰疬;天泡疮;湿疹;疖肿①《分类草药性》:解毒杀虫,叶治天泡疮。"②《天宝本草》:治小儿臌胀,疳疾。"③《四川中药志》:利尿,消痃癖,去骨蒸劳热。治黄疸,小便不利,久咳喘急;外涂小儿泡疮及皮肤湿热疮。单用果效力更佳。"④广州部队《常用中草药手册》:感冒发热,咽喉肿痛;急性支气管炎;
湿疮肿毒。"
鞭叶铁线蕨:
【性味】苦微甘,平。
【功用主治-鞭叶铁线蕨的功效】清热解毒,利水消肿。
【选方】①治水肿:岩虱子二两,煨水服。②治乳痈,黄水疮:岩虱子研末敷患处。
具体实施方式:
实施例1,配方:
每100mg的乙醇中含:赤小豆10mg、血藤10mg、茄根10mg、薏苡仁10mg、五加皮8mg、附子8mg、小麦麸8mg、地骨皮8mg、威灵仙6mg、黄柏6mg、小叶金老梅6mg、玉米须6mg、紫花地丁4mg、棱枝槲寄生4mg、灯笼草4mg、鞭叶铁线蕨4mg、冰片1mg、薄荷油1mg。
制备方法:
1)、按配方比例将上述中药粉碎成300-400目的细粉备用;
2)、按配方比例将乙醇中加入粉碎后的细粉搅拌均匀,在于加入冰片勾兑,最后加入薄荷油搅拌均匀,于0-10℃温度下用超声波匀化10-30分钟,分装即为成品。
用法:外搽,每日3-4次,连用2-4周。适应症:各种类型的癣。
实施例2,配方:
每100mg的乙醇中含:赤小豆11mg、血藤11mg、茄根11mg、薏苡仁11mg、五加皮9mg、附子9mg、小麦麸9mg、地骨皮9mg、威灵仙7mg、黄柏7mg、小叶金老梅7mg、玉米须7mg、紫花地丁5mg、棱枝槲寄生5mg、灯笼草5mg、鞭叶铁线蕨5mg、冰片2mg、薄荷油2mg。
制备方法与实施例1相同。
实施例3,配方:
每100mg的乙醇中含:赤小豆15mg、血藤15mg、茄根15mg、薏苡仁15mg、五加皮13mg、附子13mg、小麦麸13mg、地骨皮13mg、威灵仙8mg、黄柏8mg、小叶金老梅8mg、玉米须8mg、紫花地丁6mg、棱枝槲寄生6mg、灯笼草6mg、鞭叶铁线蕨6mg、冰片5mg、薄荷油5mg。
制备方法与实施例1相同。
实施例4,配方:
每100mg的乙醇中含:赤小豆18mg、血藤18mg、茄根18mg、薏苡仁18mg、五加皮14mg、附子14mg、小麦麸14mg、地骨皮14mg、威灵仙9mg、黄柏9mg、小叶金老梅9mg、玉米须9mg、紫花地丁7mg、棱枝槲寄生7mg、灯笼草7mg、鞭叶铁线蕨7mg、冰片8mg、薄荷油8mg。
制备方法与实施例1相同。
实施例5,配方:
每100mg的乙醇中含:赤小豆20mg、血藤20mg、茄根20mg、薏苡仁20mg、五加皮15mg、附子15mg、小麦麸15mg、地骨皮15mg、威灵仙10mg、黄柏10mg、小叶金老梅10mg、玉米须10mg、紫花地丁8mg、棱枝槲寄生8mg、灯笼草8mg、鞭叶铁线蕨8mg、冰片10mg、薄荷油10mg。
制备方法与实施例1相同。
本发明的有益效果是:
有利于皮肤的生理功能的发挥;既有治疗作用,又有保护皮肤的作用,比单纯应用乙醇和高锰酸钾具有多重治疗效果,使用过程中减少了皮肤的干燥、紧张感,而且刺激性小,患者易于接受,应用前景广阔。配方中使用高锰酸钾能有效杀灭细菌,水杨酸可以杀灭细菌、真菌、病毒、阿米巴原虫等,可用来治疗许多细菌性、真菌性、病毒性等皮肤病。影响其趋化性,影响某些细胞因子的表述,抑制炎症的发生过程,具有双重抗炎作用。醋能增加皮肤粘膜的新陈代谢和抑制过敏反应,促进细胞的生长。本方中选用中草药均具有针对性,具有抗菌、消炎、杀毒、排毒、排脓等作用,能够溶解稀释毛囊口内的皮脂,以利于脱落细胞的排出,减少继发感染的机会,同时对皮肤有保湿、滋润和延长局部药效的作用。冰片和薄荷油具有清凉解毒、护肤的作用,最终减少细菌和炎症性真菌、脓疱的形成。
治疗脚癣疗效观察
脚癣是皮肤科的常见病,我们于2000年-2012年采用自制脚气制剂治疗脚癣病例500多例,取得良好效果,现总结如下。
典型临床病例入选标准:
入选标准:具有典型的临床表现,符合Ⅱ级寻常性痤疮的诊断标准,一月内未做任何药物治疗,无合并其他疾病。
剔除标准:对本品过敏者;长期应用皮质类固醇激素者;症状性脚癣;中断治疗及不能复诊者。
入选病例60例,其中男性38例.女性22例,最小年龄18岁,最大63岁,平均年龄34岁,其中水疱型31例,糜烂型20例,角化型9例,病人患病至就诊时间最长3年多,最短一年多。临床症状:局部有散在的小水疱、糜烂渗出、疼痛、肿胀、奇痒、功能障碍等。
典型病例
病例1:
赵xx,患脚气多年,曾经用过很多的药膏、药水都是当时很好用,过一阶段就又犯了,经常出现小泡泡而且面积不断扩大,脚干脱皮,目前脚趾已有灰指甲,脚部的皮肤颜色较深(象似疤痕),使用本发明药物二周症状完全消失,三年未复发。
病例2:
许xx,脚气是妻子传染的,经常在脚趾上长出来很多水泡,很痒。经常把水泡挤破,然后涂抹达克宁之类的软膏,这样可以支持几天,但是经常是死灰复燃。脚气水,足光粉,还有各种软膏都用遍了,现在还是老样子,而且长水泡的面积好像越来越大,使用本发明药物三周症状完全消失,至今未复发。
病例3:
刘XX,务农脚缝脱皮而且皮下有很多黄色小水泡,来诊时脚趾甲忽然增厚,趾甲面上还有凹凸不平的小坑,趾甲而且从顶端开始蜕落,脚指甲严重变形,使用本发明药物两周症状完全消失,至今未复发。
病例4:
张XX2007年患了'香港脚',脱皮起水泡,奇痒,脚臭,长期以来一直用药,用药方式:擦、洗、泡、抹,可效果不大。使用本发明药物7天症状完全消失,至今未复发。
病例5:
陈xx,男,28岁.张家口私厂工人。因3年前被确诊为脚气,来就诊,查体:见双脚第五与四趾间、第三与二趾间有散在的红色小水疱并有淡黄色液体渗出。局部肿胀伴有糜烂,自述奇痒难忍。使用复方酊剂,以棉签沾之外涂于患处,每天两次,连用4个疗程停药。临床症状及体症完全消失,局部皮肤完好如初而痊愈。至今未复发。
病例6:
王xx,男,45岁.张家口某学校校长。因并发严重的真菌感染而就诊,表现为发热、趾间、脚背明显肿胀,疼痛、趾间有较多的淡黄的脓液,腹股沟淋巴肿大。病人奇痒难忍,苦不堪言。经过使用本发明脚癣酊剂以棉签沾之外涂于患处,抗炎治疗、控制感染,每天两次,连用4个疗程停药痊愈,随访未复发。
病例7:
袁XX,患脚气10余年,使用多种脚气病的外用药物治疗,有一定疗效,但年年复发,未治愈,使用本发明酊剂,治疗五天见效,10天治愈,至今未复发。
病例8:
张XX,因家养宠物,全家三口被传染上真菌,脚气病严重,已有10年,曾用过多种脚气病的外用药物治疗,有一定疗效,但年年复发,未治愈,使用本发明酊剂,治疗15天见效,3疗程治愈,至今未复发。
用药及观察方法:用棉签蘸取配好的酊剂,均匀涂于患处,面积略大于皮损,早、中、晚各一次,疗程一个月。于治疗前、治疗后1周、2周、3周及4周进行临床评分。评分的方法为将临床表现炎症丘疹、脓庖按无-0,轻-1,中-2,重-3,评分后累加起来既为临床得分;治疗后临床改善率=(治疗前-10-
得分-治疗后得分)/治疗前得分×100%。
疗效判定:采用4级标准
显效:经复方脚癣酊剂治疗4个疗程,临床症状及体征基本消失,局部皮肤完好。
有效:经复方脚癣酊剂治疗4个疗程,临床症状及体征明显改善,局部皮肤损害明显减轻。
无效:经复方脚癣酊剂治疗4个疗程,临床症状及体征无明显改善,局部疼痛、肿胀无明显减轻。
痊愈临床改善率≥95%;显效临床改善率<95%,≥60%;
有效临床改善率<60%,≥20%;无效临床改善率<20%;
痊愈加显效合计为有效率。
副作用观察
本组有5例(8.3%)患者用药后出现皮肤红斑,刺激感,但未经处理自行缓解,均未中断治疗,直至疗程结束。
Claims (3)
1.一种治疗脚气的复方酊剂,其特征在于,是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆10-20份、血藤10-20份、茄根10-20份、薏苡仁10-20份、五加皮8-15份、附子8-15份、小麦麸8-15份、地骨皮8-15份、威灵仙6-10份、黄柏6-10份、小叶金老梅6-10份、玉米须6-10份、紫花地丁4-8份、棱枝槲寄生4-8份、灯笼草4-8份、鞭叶铁线蕨4-8份、冰片1-10份、薄荷油1-10份;
制备方法:
1)、按配方比例将上述中药粉碎成300-400目的细粉备用;
2)、按配方比例在乙醇中加入粉碎后的细粉搅拌均匀,再加入冰片勾兑,最后加入薄荷油搅拌均匀,于0-10℃温度下用超声波匀化10-30分钟,分装即为成品。
2.根据权利要求1所述的,一种治疗脚气的复方酊剂,其特征在于,是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆11-18份、血藤11-18份、茄根11-18份、薏苡仁11-18份、五加皮9-14份、附子9-14份、小麦麸9-14份、地骨皮9-14份、威灵仙7-9份、黄柏7-9份、小叶金老梅7-9份、玉米须7-9份、紫花地丁5-7份、棱枝槲寄生5-7份、灯笼草5-7份、鞭叶铁线蕨5-7份、冰片2-8份、薄荷油2-8份。
3.根据权利要求1所述的,一种治疗脚气的复方酊剂,其特征在于,是由以下重量配比的原料组成:
每100份的乙醇中含:赤小豆15份、血藤15份、茄根15份、薏苡仁15份、五加皮13份、附子13份、小麦麸13份、地骨皮13份、威灵仙8份、黄柏8份、小叶金老梅8份、玉米须8份、紫花地丁6份、棱枝槲寄生6份、灯笼草6份、鞭叶铁线蕨6份、冰片5份、薄荷油5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583270.0A CN102973845B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗脚气的复方酊剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583270.0A CN102973845B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗脚气的复方酊剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102973845A CN102973845A (zh) | 2013-03-20 |
CN102973845B true CN102973845B (zh) | 2014-04-02 |
Family
ID=47848380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210583270.0A Expired - Fee Related CN102973845B (zh) | 2012-12-28 | 2012-12-28 | 一种治疗脚气的复方酊剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102973845B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370842A (zh) * | 2010-08-19 | 2012-03-14 | 王士轩 | 一种治疗青春痘、脚气、皮肤癣的药物 |
-
2012
- 2012-12-28 CN CN201210583270.0A patent/CN102973845B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102973845A (zh) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102119989B (zh) | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 | |
CN105079644A (zh) | 一种可有效治疗手足癣的膏状药物及其制备方法 | |
CN101601782B (zh) | 一种治疗脚癣的复方酊剂 | |
CN103393857B (zh) | 一种治疗肝炎的药物及制备方法 | |
CN102406798A (zh) | 用于治疗重症肌无力的中药组合物 | |
CN102813900B (zh) | 一种治疗脚鸡眼的外用药 | |
CN104784346A (zh) | 一种治疗瘙痒症的中药洗剂制备方法 | |
CN104288601A (zh) | 一种皮肤止痒膏及其制备方法 | |
CN103989866A (zh) | 一种用于治疗便秘的中药及其制备方法 | |
CN105456644A (zh) | 一种用于会阴裂伤术后护理的外用洗剂及其制备方法 | |
CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
CN102973845B (zh) | 一种治疗脚气的复方酊剂 | |
CN103735914B (zh) | 一种用于预防和治疗冻疮的药膏及制备方法 | |
CN102949643B (zh) | 一种用于皮肤护理和治疗皮炎的药膏 | |
CN101766740B (zh) | 一种用于消除疤痕的中药组合物及其制备方法 | |
CN103893610A (zh) | 一种治疗手足癣的中药药膏及制备方法 | |
CN102526644A (zh) | 一种治疗胆囊结石的中药制剂 | |
CN103656071B (zh) | 一种治疗痛风的药物及其制备方法 | |
CN103751752B (zh) | 一种治疗痢疾的药物及其制备方法 | |
CN107496765A (zh) | 一种可有效治疗急性胰腺炎的中药组合物及其制备方法 | |
CN102940759B (zh) | 一种治疗猪湿疹病的中药酊剂 | |
CN105770204A (zh) | 一种治疗水疱型脚气的中药软膏及其制备方法 | |
CN105106590A (zh) | 一种用于治疗过敏性鼻炎的药物 | |
CN105395947A (zh) | 一种治疗前列腺炎的药物及其制备方法 | |
CN105412825A (zh) | 一种治疗高脂血症的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20141228 |
|
EXPY | Termination of patent right or utility model |